MolPAGE Consortium Aims to Find Biomarkers for Diabetes, Vascular Disease | GenomeWeb

NEW YORK, April 15 (GenomeWeb News) - A European consortium of 18 academic institutions, biotechnology companies, and pharmaceutical firms has been funded by 12 million ($15.5 million) from the European Union to identify biomarkers for diabetes and vascular disease.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.